Figures:
Table 1: Kidney cancer histological variants, laterality and TNM Staging.
 Kidney Cancer
 Incidence Per Year (%)
              2014                      23 (35.9%)
              2015                      6 (9.3%)
              2016                      14 (21.9%)
              2017                      6 (9.3%)
              2018                      15 (23.4)
 Histological Variant
                 Clear Cell              24 (37.5%)
                 Papillary Clear Cell    4 (6.3%)
                 Chromophobe             2 (3.1%)
                 Clear Cell
                 Collision               1 (1.6%)
                 (Chromophobe       +
                 Clear Cell)
                 Unclassified Clear      1 (1.6%)
                 Cell
                 Oncocytoma              1 (1.6%)
                 Liposarcoma             1 (1.6%)
                 Missing                 30 (46.9%)
 Laterality
                 Right                   24 (37.5%)
                 Left                    20 (31.3%)
                 Missing                 20 (31.3%)
 TNM Staging
    T
                 T1                      21 (32.8%)
                 T2                      5 (7.8%)
                 T3                      8 (12.5%)
                 T4                      2 (3.1%)
                 Missing                 28 (43.8%)
     N
                 N0                      34 (53.1%)
                 N1                      9 (14.1%)
                 Missing                 21 (32.8%)
     M
                 M0                      33 (51.6%)
                 M1                      8 (12.5%)
                 Missing                 23 (35.9%)
   Stage
                 Stage 1                 23 (35.9%)
                 Stage 2                 3 (4.7%)
                 Stage 3                 7 (10.9%)
                 Stage 4                 6 (9.4%)
                 Missing                 25 (39.1%)